# Organigram Global Inc.: financial statements, quarterly

OGI · Nasdaq · CIK 1620737 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/ogi.md) · [Financials](/companies/ogi/financials.md) · [Filings](/companies/ogi/filings.md) · [Insiders](/companies/ogi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ogi/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2017-08-31) | period not labelled (2018-08-31) | FY2019 (2019-08-31) | FY2020 (2020-08-31) | FY2021 (2021-08-31) | FY2022 (2022-08-31) | FY2024 (2023-09-30) | FY2024 (2024-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Current assets | $m | not reported | [203](/filings/0001062993-19-004846.md) | [196](/filings/0001062993-20-005949.md) | [170](/filings/0001062993-21-011478.md) | [261](/filings/0001628280-22-030921.md) | [222](/filings/0001628280-23-041900.md) | [156](/filings/0001628280-24-051826.md) | [262](/filings/0001628280-24-051826.md) |
| Total assets | $m | not reported | [303](/filings/0001062993-19-004846.md) | [429](/filings/0001062993-20-005949.md) | [435](/filings/0001062993-21-011478.md) | [554](/filings/0001628280-22-030921.md) | [577](/filings/0001628280-23-041900.md) | [298](/filings/0001628280-24-051826.md) | [408](/filings/0001628280-24-051826.md) |
| Current liabilities | $m | not reported | [11.3](/filings/0001062993-19-004846.md) | [43.9](/filings/0001062993-20-005949.md) | [29.1](/filings/0001062993-21-011478.md) | [26.3](/filings/0001628280-22-030921.md) | [55.3](/filings/0001628280-23-041900.md) | [22.4](/filings/0001628280-24-051826.md) | [53.3](/filings/0001628280-24-051826.md) |
| Total liabilities | $m | not reported | [118](/filings/0001062993-19-004846.md) | [102](/filings/0001062993-20-005949.md) | [136](/filings/0001062993-21-011478.md) | [74.2](/filings/0001628280-22-030921.md) | [69.0](/filings/0001628280-23-041900.md) | [26.8](/filings/0001628280-24-051826.md) | [102](/filings/0001628280-24-051826.md) |
| Shareholders' equity | $m | [82.9](/filings/0001062993-19-004846.md) | [185](/filings/0001062993-20-005949.md) | [327](/filings/0001062993-21-011478.md) | [300](/filings/0001628280-22-030921.md) | [480](/filings/0001628280-23-041900.md) | [508](/filings/0001628280-24-051826.md) | [272](/filings/0001628280-24-051826.md) | [306](/filings/0001628280-24-051826.md) |

- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 108,585,492 at 2024-09-30, from the cover of the [40-F filed 2024-12-18](/filings/0001628280-24-051826.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.